Insider Buying: Olaplex Holdings, Inc. (NASDAQ:OLPX) Director Buys $90,469.75 in Stock

Olaplex Holdings, Inc. (NASDAQ:OLPXGet Free Report) Director John P. Bilbrey bought 51,697 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was bought at an average price of $1.75 per share, for a total transaction of $90,469.75. Following the completion of the acquisition, the director now directly owns 318,418 shares in the company, valued at approximately $557,231.50. The trade was a 19.38 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Olaplex Stock Up 1.7 %

Shares of NASDAQ OLPX traded up $0.03 during mid-day trading on Tuesday, reaching $1.75. The company had a trading volume of 1,960,825 shares, compared to its average volume of 2,414,949. The company has a debt-to-equity ratio of 0.73, a quick ratio of 10.32 and a current ratio of 11.84. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of 28.67 and a beta of 2.47. The stock has a fifty day moving average of $2.11 and a two-hundred day moving average of $1.91. Olaplex Holdings, Inc. has a 12-month low of $1.19 and a 12-month high of $2.98.

Olaplex (NASDAQ:OLPXGet Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.04. Olaplex had a net margin of 9.78% and a return on equity of 10.50%. The company had revenue of $119.10 million during the quarter, compared to the consensus estimate of $126.51 million. During the same quarter in the prior year, the firm earned $0.05 EPS. The company’s revenue was down 3.6% compared to the same quarter last year. As a group, equities research analysts expect that Olaplex Holdings, Inc. will post 0.11 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Olaplex by 27.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 30,957 shares of the company’s stock valued at $60,000 after buying an additional 6,614 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in shares of Olaplex by 38.9% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 25,819 shares of the company’s stock valued at $40,000 after purchasing an additional 7,235 shares during the last quarter. Abel Hall LLC boosted its holdings in Olaplex by 68.1% in the third quarter. Abel Hall LLC now owns 18,261 shares of the company’s stock worth $43,000 after purchasing an additional 7,397 shares in the last quarter. Catalina Capital Group LLC increased its position in Olaplex by 51.3% during the second quarter. Catalina Capital Group LLC now owns 24,088 shares of the company’s stock worth $37,000 after buying an additional 8,172 shares during the last quarter. Finally, Sanders Morris Harris LLC lifted its position in shares of Olaplex by 2.9% in the third quarter. Sanders Morris Harris LLC now owns 354,000 shares of the company’s stock worth $832,000 after buying an additional 10,000 shares during the last quarter. Hedge funds and other institutional investors own 87.37% of the company’s stock.

Wall Street Analyst Weigh In

OLPX has been the topic of a number of analyst reports. TD Cowen lifted their price target on Olaplex from $1.80 to $2.00 and gave the stock a “hold” rating in a research note on Wednesday, August 7th. Telsey Advisory Group reissued a “market perform” rating and issued a $3.00 target price on shares of Olaplex in a research report on Thursday, November 7th. Finally, Barclays reduced their price target on shares of Olaplex from $2.00 to $1.50 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Olaplex has a consensus rating of “Hold” and an average price target of $2.30.

Read Our Latest Stock Analysis on OLPX

About Olaplex

(Get Free Report)

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.

Read More

Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.